Brent B. is a molecular and cell biologist currently serving as a Senior Director in clinical biomarker development at Eli Lilly, where they focus on translational biomarker research in oncology. With a strong background in cancer biology and extensive experience in techniques such as flow cytometry and biochemistry, Brent has previously held roles at Merck and the University of Colorado, contributing to significant advancements in apoptosis and biomarker discovery. They earned a Ph.D. in Cancer Biology from the University of Arizona and a Bachelor’s degree in Biology and Chemistry from Point Loma Nazarene University, both with top honors. Recognized for their communication skills and innovative approach, Brent excels in both collaborative and individual projects.
This person is not in any teams
This person is not in any offices